Document Detail

Lactate in cystic fibrosis sputum.
MedLine Citation:
PMID:  20947455     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: Antibiotic therapy is thought to improve lung function in patients with cystic fibrosis (CF) by decreasing neutrophil-derived inflammation. We investigated the origin and clinical significance of lactate in the chronically inflamed CF lung.
METHODS: Lactate was measured in sputa of 18 exacerbated and 25 stable CF patients via spectrophotometry and gaschromatography. Lung function was assessed via spirometry. Seven patients with chronic obstructive pulmonary disease (COPD) and three patients with acute lung inflammation served as control groups. Neutrophil and bacterial lactate production was assessed under aerobic and anaerobic conditions.
RESULTS: In sputum specimens of patients with respiratory exacerbations lactate concentrations decreased significantly (p<0.005) from 3.4±2.3mmol/L to 1.4±1.4mmol/L after 2-3weeks of intravenous antibiotics. Successful treatment was reflected in 16 patients (88.9%) by FVC increase associated with lactate decrease (p<0.05). In every single sputum lactate was detectable (3.0±3.1mmol/L, range 0.2-14.1mmol/L). Lactate was lower (1.6±0.8mmol/L) in sputa from seven COPD patients, and it was below the detection limit in three patients with acute lung inflammation. Neutrophil lactate production accumulated up to 10.5mmol/L after 4days, whereas bacterial lactate production did not appear to contribute substantially to sputum lactate concentrations.
CONCLUSIONS: Successful antibiotic therapy is reflected by a decrease in lactate concentrations. Neutrophils are the most likely source for lactate in sputum of CF patients. Therefore lactate may be used to monitor responses to antibiotic therapy as an adjunct to lung function measurements.
Tobias Bensel; Martin Stotz; Marianne Borneff-Lipp; Bettina Wollschläger; Andreas Wienke; Giovanni Taccetti; Silvia Campana; Keith C Meyer; Peter Ø Jensen; Ute Lechner; Martina Ulrich; Gerd Döring; Dieter Worlitzsch
Related Documents :
9184975 - Nasal mucociliary transport and ciliary ultrastructure in cystic fibrosis. a comparativ...
7708805 - Defective inhibition by dexamethasone of leukotriene b4 and c4 production by leukocytes...
1690795 - Renal calcium handling in cystic fibrosis: lack of evidence for a primary renal defect.
11115445 - Complications of indwelling catheters in cystic fibrosis: a 10-year review.
6610425 - Systemic lupus erythematosus with paraproteinemia.
20975635 - Cardiovascular risk profile in systemic lupus erythematosus and rheumatoid arthritis: a...
Publication Detail:
Type:  Journal Article     Date:  2010-10-13
Journal Detail:
Title:  Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society     Volume:  10     ISSN:  1873-5010     ISO Abbreviation:  J. Cyst. Fibros.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-01-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101128966     Medline TA:  J Cyst Fibros     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  37-44     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
Institute of Hygiene, University Hospital of Halle-Wittenberg, Halle, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A novel defect in mitochondrial p53 accumulation following DNA damage confers apoptosis resistance i...
Next Document:  Methodological contributions towards LC-MS/MS quantification of free VX in plasma: An innovative app...